Sangamo Therapeutics, Inc. (LON:0R1D)

Sangamo Therapeutics Statistics

Total Valuation

LON:0R1D has a market cap or net worth of GBP 143.61 million. The enterprise value is 132.43 million.

Market Cap	143.61M
Enterprise Value	132.43M

Important Dates

The next estimated earnings date is Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	301.71M
Shares Outstanding	n/a
Shares Change (YoY)	+20.61%
Shares Change (QoQ)	+16.65%
Owned by Insiders (%)	1.18%
Owned by Institutions (%)	17.26%
Float	294.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.41
PB Ratio	10.04
P/TBV Ratio	10.04
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-2.87
EV / Sales	2.16
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.01

Financial Position

The company has a current ratio of 1.05, with a Debt / Equity ratio of 1.20.

Current Ratio	1.05
Quick Ratio	0.91
Debt / Equity	1.20
Debt / EBITDA	n/a
Debt / FCF	-0.65
Interest Coverage	-17.19

Financial Efficiency

Return on equity (ROE) is -292.47% and return on invested capital (ROIC) is -81.82%.

Return on Equity (ROE)	-292.47%
Return on Assets (ROA)	-41.15%
Return on Invested Capital (ROIC)	-81.82%
Return on Capital Employed (ROCE)	-125.74%
Revenue Per Employee	325,886
Profits Per Employee	-252,502
Employee Count	183
Asset Turnover	0.86
Inventory Turnover	n/a

Taxes

Income Tax	-140,871
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -55.18% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-55.18%
50-Day Moving Average	0.60
200-Day Moving Average	0.71
Relative Strength Index (RSI)	50.87
Average Volume (20 Days)	93,147

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.15

Income Statement

In the last 12 months, LON:0R1D had revenue of GBP 59.64 million and -46.21 million in losses. Loss per share was -0.21.

Revenue	59.64M
Gross Profit	-16.64M
Operating Income	-45.80M
Pretax Income	-46.35M
Net Income	-46.21M
EBITDA	-42.53M
EBIT	-45.80M
Loss Per Share	-0.21

Balance Sheet

The company has 27.99 million in cash and 17.12 million in debt, giving a net cash position of 10.86 million.

Cash & Cash Equivalents	27.99M
Total Debt	17.12M
Net Cash	10.86M
Net Cash Per Share	n/a
Equity (Book Value)	14.31M
Book Value Per Share	0.05
Working Capital	1.63M

Cash Flow

In the last 12 months, operating cash flow was -26.20 million and capital expenditures -212,401, giving a free cash flow of -26.42 million.

Operating Cash Flow	-26.20M
Capital Expenditures	-212,401
Free Cash Flow	-26.42M
FCF Per Share	n/a

Margins

Gross margin is -27.89%, with operating and profit margins of -76.79% and -77.48%.

Gross Margin	-27.89%
Operating Margin	-76.79%
Pretax Margin	-77.72%
Profit Margin	-77.48%
EBITDA Margin	-71.32%
EBIT Margin	-76.79%
FCF Margin	n/a

Dividends & Yields

LON:0R1D does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.61%
Shareholder Yield	-20.61%
Earnings Yield	-32.17%
FCF Yield	-18.39%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0R1D has an Altman Z-Score of -21.84 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-21.84
Piotroski F-Score	4